Transcription of Stability Existing Corrected March 2007
{{id}} {{{paragraph}}}
Example: bankruptcy
Stability Existing Corrected March 2007
European Medicines Agency Inspections 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 85 95 E-mail: @EMEA 2007 Reproduction and/or distribution of this document is authorised for non-commercial purposes only provided the EMEA is acknowledged London, 17 December 2003 CPMP/QWP/122/02, rev 1 corr COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE ON Stability testing : Stability testing OF Existing active SUBSTANCES AND RELATED FINISHED PRODUCTS DISCUSSION IN THE QUALITY WORKING PARTY (QWP) October 2003 TRANSMISSION TO THE CPMP December 2003 ADOPTION OF THE REVISION BY THE CPMP December 2003 DATE FOR COMING INTO OPERATION March 2004 Note: This guideline includes a minor correction to the earlier version CPMP/QWP/122/02 corr. and CPMP/QWP/122/02, which came into operation in June 2003.
CPMP/QWP/122/02, rev 1 corr EMEA 2007 3/18 STABILITY TESTING OF EXISTING ACTIVE SUBSTANCES AND RELATED FINISHED PRODUCTS 1. INTRODUCTION 1.1 Objectives of the Guideline
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
STABILITY TESTING OF ACTIVE PHARMACEUTICAL, Stability, Active substances, STABILITY TESTING OF ACTIVE SUBSTANCES AND, Stability testing of active substances and pharmaceutical products, Q1A(R2) Guideline Stability Testing of New, Substances, STABILITY TESTING, Stability Testing of Pharmaceutical, Stability testing of pharmaceutical products, STABILITY TESTING OF ACTIVE, PHARMACEUTICAL INGREDIENTS AND, FINISHED PHARMACEUTICAL PRODUCTS, Stability Testing of Drug Substances, Registration of Medicines Stability, Registration of Medicines Stability Stability